Skip to content

04 September 2026

Falsified Drugs, Misinformation and Systemic Risk: Lessons from the ECRI & ISMP Patient Safety Report

Share:

Each year, ECRI and the Institute for Safe Medication Practices (ISMP) compile their definitive Top 10 Patient Safety Concerns report. By analysing scientific literature, adverse event databases, and insights from interdisciplinary healthcare leaders, including physicians, nurses and pharmacy professionals, the list identifies the most urgent institutional vulnerabilities facing healthcare delivery.

As detailed in a review by Pharmacy Practice News, the ECRI/ISMP report highlights critical, emerging risks ranging from the viral spread of medical misinformation and falsified pharmaceuticals to diagnostic errors and the dismissal of patient concerns.

Key Systemic Vulnerabilities in Modern Care

While medication safety historically focused on internal hospital processes such as dosage calculations or sound-alike drug names, the ECRI and ISMP findings demonstrate that systemic, structural factors now directly compromise bedside care across multiple fronts:

  • The Spread of Falsified and Substandard Drugs: Driven by global supply chain disruptions and unregulated online sales, counterfeit or substandard medications pose a severe threat. When non-potent, incorrect or toxic formulations reach a patient, the result is often rapid treatment failure, adverse drug reactions or preventable death.

  • Medical Misinformation & Health Literacy: False medical narratives spread rapidly online, leading patients to delay evidence-based treatments or engage in unverified therapies. Pharmacy professionals and clinicians play a critical role in offering empathetic, evidence-based guidance to counter these risks.

  • Dismissal of Patient and Family Concerns: The report highlights that dismissing or minimising a patient's reported symptoms severely undermines diagnostic accuracy. When a patient's warning signs or reported side effects are ignored, crucial opportunities to prevent severe harm or catch deteriorating conditions are missed.

  • AI Governance and Cybersecurity Deficits: The rapid integration of artificial intelligence and digital records into clinical workflows without strict human oversight creates new risks, including diagnostic bias and software downtime during cyber breaches that disrupt time-sensitive medication dispensing.

Clinical Responsibility and the Legal Standard of Care

From a legal perspective, these systemic risks require healthcare institutions and clinical teams to enforce robust verification and communication safeguards across three key operational areas:

  1. Enforcing strict pedigree checks on drug sourcing to ensure substandard or falsified pharmaceuticals never enter clinical inventory.

  2. Ensuring that when a patient or family member raises concerns about worsening symptoms or adverse drug reactions, clinicians conduct a formal review rather than dismissing the feedback.

  3. Providing clear, transparent communication regarding complex medication regimens and ensuring that technology (such as automated prescribing software) supports, rather than overrides, sound clinical judgment.

Under Irish law, healthcare providers and hospital systems owe a strict duty of care to maintain safe clinical environments, verify medication authenticity and act promptly when a patient exhibits signs of deterioration or treatment failure. When an institution fails to maintain these basic safety protocols, resulting patient harm represents a clear failure of institutional oversight.

Holding Systems Accountable

Whether an adverse outcome stems from a failure to heed a patient's worsening symptoms, a breakdown in medication verification or an unaddressed diagnostic delay, a thorough legal investigation is essential. Examining institutional quality control and clinical protocols allows us to uncover the truth and ensure that patient rights are fully protected.

Has your health or the health of a family member been impacted by a medication error, a delayed diagnosis or ignored clinical concerns? Contact Whelan Law today to discuss your experience with our specialised medical negligence team and ensure your case is reviewed against established clinical safety standards.

Share: